Nwizu, C.R. et al. 2026. Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol as Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy. Tropical Journal of Phytochemistry and Pharmaceutical Sciences. 5, 2 (Apr. 2026), 468–474. DOI:https://doi.org/10.26538/tjpps/v5i2.4.